Scholarlink

<p>Despite availability of multivalent vaccines, leptospirosis remains a major concern in dogs, yet its epidemiology and associated risk factors are still poorly defined. Integrating molecular, serological, clinico-pathological, hemato-biochemical, spatio-temporal, and demographic data on 905 cases across metropolitan France, this study characterises the contemporary epidemiology of dog leptospirosis. From 2020 to 2024, 4,839 dogs with suspected infection were tested by qPCR, with genotyping of qPCR-positive (<i>lfb1</i> gene) samples, and microscopic agglutination tests (MAT) were performed on serum samples. Overall, 18.7% of suspected dogs were qPCR-positive (median age = 3 years). Annual incidence peaked in 2024 with an estimated 2.72 cases per 100,000 dog-years at risk. Spatio-temporal patterns showed strong seasonality (July-October) and southern hotspots. Seven species-group (SGs) were evidenced, dominated by <i>Leptospira interrogans</i> SG5 (47.3%), associated with serogroup Australis, and <i>L. interrogans</i> SG1 (45.6%, serogroup Icterohaemorrhagiae). Clinically, most cases presented with a core syndrome, though <i>L. interrogans</i> SG1 was strongly associated with icterus. Urine qPCR outperformed blood qPCR test, especially during the acute phase. Vaccination significantly reduced risk of icterus but not mortality. These findings confirm that leptospirosis persists in dogs despite vaccination and remains a clinical challenge, underscoring the need for prevention strategies tailored to circulating serogroups, particularly in young dogs.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

A multidimensional epidemiological study of 905 canine leptospirosis cases, metropolitan France, 2020–2024

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年7月31日

查看全文
  • Kristina Museux,
  • Amélie Desvars-Larrive,
  • Pascale Bourhy,
  • Alexandre Giraud-Gatineau,
  • Céline Lorioux,
  • Corine Boucraut,
  • Mathieu Picardeau

摘要

Despite availability of multivalent vaccines, leptospirosis remains a major concern in dogs, yet its epidemiology and associated risk factors are still poorly defined. Integrating molecular, serological, clinico-pathological, hemato-biochemical, spatio-temporal, and demographic data on 905 cases across metropolitan France, this study characterises the contemporary epidemiology of dog leptospirosis. From 2020 to 2024, 4,839 dogs with suspected infection were tested by qPCR, with genotyping of qPCR-positive (lfb1 gene) samples, and microscopic agglutination tests (MAT) were performed on serum samples. Overall, 18.7% of suspected dogs were qPCR-positive (median age = 3 years). Annual incidence peaked in 2024 with an estimated 2.72 cases per 100,000 dog-years at risk. Spatio-temporal patterns showed strong seasonality (July-October) and southern hotspots. Seven species-group (SGs) were evidenced, dominated by Leptospira interrogans SG5 (47.3%), associated with serogroup Australis, and L. interrogans SG1 (45.6%, serogroup Icterohaemorrhagiae). Clinically, most cases presented with a core syndrome, though L. interrogans SG1 was strongly associated with icterus. Urine qPCR outperformed blood qPCR test, especially during the acute phase. Vaccination significantly reduced risk of icterus but not mortality. These findings confirm that leptospirosis persists in dogs despite vaccination and remains a clinical challenge, underscoring the need for prevention strategies tailored to circulating serogroups, particularly in young dogs.